Cross et al reported a score for predicting cirrhosis in a patient with chronic viral hepatitis C (HCV). The authors are from King's College Hospital and King's College in London.
Patient selection: chronic HCV
Outcomes: significant fibrosis defined as Ishak fibrosis F3 to F6 (range from 0 to 6), with cirrhosis defined as F5 or F6
Parameters:
(1) age in years
(2) AST in IU/L (Advia 2400, Siemens with reference range 10 to 50 IU/L)
(3) INR
(4) platelet count (factor * 10^9/L)
score =
= (age) * (AST) * (INR) / (platelet count factor)
Interpretation:
• A score >= 16.7 was associated with cirrhosis in 34% of patients with an odds ratio of 36.2. The negative predictive value was 96%.
• A score >= 12.3 was associated with F3-F6 fibrossi with an odds ratio of 33.9
Performance:
• Variation in the method for determining AST will affect performance.
• The area under the ROC curve is 0.79 for predicting of significant fibrosis and 0.91 for cirrhosis.
Purpose: To identify a patient with chronic viral hepatitis C (HCV) with significant hepatic fibrosis or cirrhosis using the King's score.
Specialty: Gastroenterology, Infectious Diseases
Objective: risk factors, other testing, disease progression
ICD-10: K74.6, B18.2,